Expression of morphine-conditioned hyperactivity is attenuated by naloxone and pimozide

Area of Science:

• Neuropharmacology
• Behavioral Neuroscience
• Addiction Research

Background:

• Morphine, an opiate agonist, can induce hyperactivity.
• Conditioned responses to drugs are a key aspect of addiction.
• Understanding the neurobiological basis of conditioned drug effects is crucial.

Purpose of the Study:

• To investigate whether naloxone and pimozide can attenuate morphine-conditioned hyperactivity.
• To explore the neuropharmacological substrates underlying morphine-induced unconditioned and conditioned hyperactivity.

Main Methods:

• Rats received repeated pairings of morphine (2 mg/kg) with a distinctive environment.
• Unconditioned hyperactivity was assessed after morphine administration.
• Conditioned hyperactivity was measured upon exposure to the environment without morphine.
• The effects of naloxone and pimozide on both unconditioned and conditioned hyperactivity were evaluated.

Main Results:

• Both naloxone and pimozide blocked morphine-induced unconditioned hyperactivity.
• Rats displayed a hyperactive conditioned response (CR) after drug-environment pairings.
• Naloxone (1 mg/kg) counteracted the CR.
• Pimozide attenuated the CR in a dose-dependent manner (0.25–0.4 mg/kg).

Conclusions:

• The findings suggest that similar neuropharmacological mechanisms underlie morphine's unconditioned and conditioned hyperactive effects.
• Dopaminergic pathways, modulated by pimozide, play a role in conditioned hyperactivity.
• Opiate receptor involvement, indicated by naloxone's effects, is also implicated in conditioned responses.